search
Back to results

Improving Functioning in Peripheral Arterial Disease

Primary Purpose

Cardiovascular Diseases, Peripheral Vascular Diseases

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Exercise
Diet
Sponsored by
Northwestern University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cardiovascular Diseases

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: 150 peripheral arterial disease patients with and without IC Exclusion Criteria: Below or above-knee amputation Wheelchair confinement Inability to walk on a treadmill or inability to perform progressive resistance training Inability to return to the medical center three times weekly for 6 months Walking impairment due to a cause other than PAD Class II New York Heart Association (NYHA) heart failure or angina (heart failure or angina occurring at rest or with minimal exertion) Planned lower extremity revascularization or any other major surgery within 12 months Any increase in anginal symptoms during the previous 6 months or angina at rest Subjects with silent coronary ischemia, defined as ST segment depression greater than or equal to 1 mm during baseline exercise treadmill test without associated chest discomfort, unless they have had a normal perfusion stress test during the previous 6 months Subjects with left-bundle branch block or significant ST-T wave changes on their baseline ECG who do not have a perfusion stress test demonstrating absence of reversible ischemia within the previous 6 months Lower extremity revascularization, major orthopedic surgery, or other major surgery during the previous 3 months Myocardial infarction or coronary artery bypass grafting during the previous 3 months Major medical illnesses that may interfere with subject's ability to complete the interventions and/or follow-up testing Current foot ulcer ABI greater than 0.95 Life expectancy less than 12 months Does not speak English Patient is currently involved in another clinical trial Dementia Poorly controlled blood pressure Current significant exercise, defined as exercising three times weekly for 30 minutes with sufficient exertion to produce a sweat or other exercise that is comparable to the exercise interventions offered in our protocol Treatment for cancer (other than non-melanoma skin cancer) during the past 12 months (including radiation therapy, chemotherapy, or surgery)

Sites / Locations

  • Northwestern University Feinberg School of Medicine

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Active Comparator

Arm Label

1

2

3

Arm Description

6-month supervised treadmill exercise program

6-month supervised lower extremity progressive resistance training program

Diet/nutrition control group

Outcomes

Primary Outcome Measures

Six-minute walk distance
Summary performance score

Secondary Outcome Measures

Full Information

First Posted
March 22, 2005
Last Updated
July 24, 2012
Sponsor
Northwestern University
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
search

1. Study Identification

Unique Protocol Identification Number
NCT00106327
Brief Title
Improving Functioning in Peripheral Arterial Disease
Official Title
Improving Functioning in Peripheral Arterial Disease
Study Type
Interventional

2. Study Status

Record Verification Date
July 2012
Overall Recruitment Status
Completed
Study Start Date
September 2003 (undefined)
Primary Completion Date
July 2008 (Actual)
Study Completion Date
March 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Northwestern University
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to compare the effects of nutrition, a supervised treadmill exercise program, and supervised progressive resistance training program on peripheral arterial disease.
Detailed Description
BACKGROUND: Previous work demonstrates that functional limitations associated with peripheral arterial disease (PAD) are diverse and include slower walking speed, poorer walking endurance, and impaired balance as compared to persons without PAD. Although treadmill-walking exercise improves treadmill performance in patients with intermittent claudication (IC), treadmill performance does not correlate well with community walking ability in older men and women. In older patient populations without PAD, resistance training improves functioning and walking endurance, but this mode of exercise has not been sufficiently studied in PAD. Furthermore, although 65% to 70% of men and women with PAD are either asymptomatic or have exertional leg symptoms other than IC, no prior studies have assessed the effects of exercise interventions in PAD patients who do not have IC. DESIGN NARRATIVE: The randomized, control study will determine whether a 6-month supervised treadmill exercise program and a supervised lower extremity progressive resistance training program, respectively, improve lower extremity functioning compared to a nutrition control group among 150 PAD patients with and without IC. The investigators hypothesize that participants in the treadmill walking exercise program and participants in the progressive resistance training program, respectively, will experience greater improvement in functional outcomes than participants in the nutrition control group. The primary functional outcome measures in descending order of importance are 6-minute walk distance and the summary performance score. The summary performance score is a composite measure of lower extremity functioning (usual walking speed, standing balance, and time required for five repeated chair rises) measured on a 0-12 scale that predicts future risk of nursing home placement, mobility loss, and mortality. The study will also identify mechanisms by which the exercise interventions improve functioning in PAD. Mechanisms to be studied include changes in blood viscosity, calf blood flow, brachial artery endothelial reactivity, and inflammatory cytokine levels. By identifying the optimal exercise program for improving functioning in PAD patients with and without IC, the findings will have substantial clinical and public health implications for millions of patients with PAD.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiovascular Diseases, Peripheral Vascular Diseases

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
156 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
6-month supervised treadmill exercise program
Arm Title
2
Arm Type
Experimental
Arm Description
6-month supervised lower extremity progressive resistance training program
Arm Title
3
Arm Type
Active Comparator
Arm Description
Diet/nutrition control group
Intervention Type
Behavioral
Intervention Name(s)
Exercise
Intervention Description
6 months of supervised treadmill exercise or strength training, three times per week, followed by a 6 month home-based program.
Intervention Type
Behavioral
Intervention Name(s)
Diet
Intervention Description
11 nutrition education sessions
Primary Outcome Measure Information:
Title
Six-minute walk distance
Time Frame
Measured at baseline and follow-up study visits
Title
Summary performance score
Time Frame
Measured at baseline and follow-up study visits

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 150 peripheral arterial disease patients with and without IC Exclusion Criteria: Below or above-knee amputation Wheelchair confinement Inability to walk on a treadmill or inability to perform progressive resistance training Inability to return to the medical center three times weekly for 6 months Walking impairment due to a cause other than PAD Class II New York Heart Association (NYHA) heart failure or angina (heart failure or angina occurring at rest or with minimal exertion) Planned lower extremity revascularization or any other major surgery within 12 months Any increase in anginal symptoms during the previous 6 months or angina at rest Subjects with silent coronary ischemia, defined as ST segment depression greater than or equal to 1 mm during baseline exercise treadmill test without associated chest discomfort, unless they have had a normal perfusion stress test during the previous 6 months Subjects with left-bundle branch block or significant ST-T wave changes on their baseline ECG who do not have a perfusion stress test demonstrating absence of reversible ischemia within the previous 6 months Lower extremity revascularization, major orthopedic surgery, or other major surgery during the previous 3 months Myocardial infarction or coronary artery bypass grafting during the previous 3 months Major medical illnesses that may interfere with subject's ability to complete the interventions and/or follow-up testing Current foot ulcer ABI greater than 0.95 Life expectancy less than 12 months Does not speak English Patient is currently involved in another clinical trial Dementia Poorly controlled blood pressure Current significant exercise, defined as exercising three times weekly for 30 minutes with sufficient exertion to produce a sweat or other exercise that is comparable to the exercise interventions offered in our protocol Treatment for cancer (other than non-melanoma skin cancer) during the past 12 months (including radiation therapy, chemotherapy, or surgery)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mary McDermott, MD
Organizational Affiliation
Northwestern University Feinberg School of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Northwestern University Feinberg School of Medicine
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60611-3008
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
34075780
Citation
McDermott MM, Tian L, Criqui MH, Ferrucci L, Greenland P, Guralnik JM, Kibbe MR, Li L, Sufit R, Zhao L, Polonsky TS. Perceived Versus Objective Change in Walking Ability in Peripheral Artery Disease: Results from 3 Randomized Clinical Trials of Exercise Therapy. J Am Heart Assoc. 2021 Jun 15;10(12):e017609. doi: 10.1161/JAHA.120.017609. Epub 2021 Jun 2.
Results Reference
derived
PubMed Identifier
32416309
Citation
Patel K, Polonsky TS, Kibbe MR, Guralnik JM, Tian L, Ferrucci L, Criqui MH, Sufit R, Leeuwenburgh C, Zhang D, Zhao L, McDermott MM. Clinical characteristics and response to supervised exercise therapy of people with lower extremity peripheral artery disease. J Vasc Surg. 2021 Feb;73(2):608-625. doi: 10.1016/j.jvs.2020.04.498. Epub 2020 May 19.
Results Reference
derived
PubMed Identifier
30587066
Citation
McDermott MM, Kibbe MR, Guralnik JM, Ferrucci L, Criqui MH, Domanchuk K, Tian L, Zhao L, Li L, Patel K, Polonsky TS. Durability of Benefits From Supervised Treadmill Exercise in People With Peripheral Artery Disease. J Am Heart Assoc. 2019 Jan 8;8(1):e009380. doi: 10.1161/JAHA.118.009380.
Results Reference
derived
PubMed Identifier
20511294
Citation
McDermott MM, Ferrucci L, Guralnik JM, Dyer AR, Liu K, Pearce WH, Clark E, Liao Y, Criqui MH. The ankle-brachial index is associated with the magnitude of impaired walking endurance among men and women with peripheral arterial disease. Vasc Med. 2010 Aug;15(4):251-7. doi: 10.1177/1358863X10365181. Epub 2010 May 28. Erratum In: Vasc Med. 2010 Dec;15(6):517.
Results Reference
derived
PubMed Identifier
19651668
Citation
Payvandi L, Dyer A, McPherson D, Ades P, Stein J, Liu K, Ferrucci L, Criqui MH, Guralnik JM, Lloyd-Jones D, Kibbe MR, Liang ST, Kane B, Pearce WH, Verta M, McCarthy WJ, Schneider JR, Shroff A, McDermott MM. Physical activity during daily life and brachial artery flow-mediated dilation in peripheral arterial disease. Vasc Med. 2009 Aug;14(3):193-201. doi: 10.1177/1358863X08101018.
Results Reference
derived
PubMed Identifier
19141764
Citation
McDermott MM, Ades P, Guralnik JM, Dyer A, Ferrucci L, Liu K, Nelson M, Lloyd-Jones D, Van Horn L, Garside D, Kibbe M, Domanchuk K, Stein JH, Liao Y, Tao H, Green D, Pearce WH, Schneider JR, McPherson D, Laing ST, McCarthy WJ, Shroff A, Criqui MH. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA. 2009 Jan 14;301(2):165-74. doi: 10.1001/jama.2008.962. Erratum In: JAMA. 2012 Apr 25;307(16):1694.
Results Reference
derived
PubMed Identifier
18829215
Citation
McDermott MM, Ades PA, Dyer A, Guralnik JM, Kibbe M, Criqui MH. Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease. J Vasc Surg. 2008 Nov;48(5):1231-7, 1237.e1. doi: 10.1016/j.jvs.2008.06.050. Epub 2008 Oct 1.
Results Reference
derived

Learn more about this trial

Improving Functioning in Peripheral Arterial Disease

We'll reach out to this number within 24 hrs